LAE-32
This is an old revision of this page, as edited by Cewbot (talk | contribs) at 00:45, 11 January 2022 (Normalize {{Multiple issues}}: Create {{Multiple issues}} with 3 maintenance template(s): Refimprove, Notability, Unreferenced). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
(Learn how and when to remove this message)
|
Clinical data | |
---|---|
Other names | LAE; Lysergic acid ethylamide; d-Lysergic acid ethylamide; d-Ethyllysergamide, |
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H21N3O |
Molar mass | 295.386 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
D-Lysergic acid ethylamide (LAE-32) is a derivative of ergine. It is reported to have some LSD-like effects but is weaker and shorter lasting, with an active dose reported to be between 0.5 and 1.5 milligrams.
It was studied by the CIA as part of Project MKULTRA. Documents published by the CIA under the Freedom of Information Act suggest it causes "a schizophrenia-like condition" but it allows people with schizophrenia to remain indifferent to their disorder.
References
Lysergic acid derivatives |
|
---|---|
Psychedelic lysergamides |
|
Clavines | |
Other ergolines | |
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
- Articles needing additional references from December 2016
- All articles needing additional references
- Articles with topics of unclear notability from November 2021
- All articles with topics of unclear notability
- Articles lacking sources from November 2021
- All articles lacking sources
- Articles with multiple maintenance issues
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- All stub articles